Page 278 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.6. Patient characteristics—race/ethnicity (continued)
Author Database Race/ethnicity 1980- 1985-1989 1990-1994 1995-1999 2000- 2005- Statistical Notes
Year 1984 2004 2010 analysis
PMID
53
Gilliland SEER- White, non- 71.7% 69.4% 76.8% NR
1996 New Hispanic 22.1% 24.4% 18.9%
8722215 Mexico Hispanic <1% 1.9% 1.5%
Black 3.8% 4.1% 2.7%
American Indian 1.5% <1% <1%
Other/unknown (1983- (1987-88) (1991-92)
84)
58
Klabunde SEER, White 91.7% 91.4% NR
1998 Medicare Black 8.3% 8.6%
9749657 (1987) (1992)
61
Zeliadt SEER, White 91.0% 89.3% NR
2004 Medicare African-American 9.0% 10.7%
15596192 (1991- (1997-
1993) 1999)
62
Carpenter SEER, White 85.8% 82.9% 83.5% P=0.043
2010 Medicare Black 14.2% 17.1% 16.5% (chi-square
20333462 (1994) (1997) (2002) test
comparing
yr of
diagnosis
between
White and
Black men,
for all yr
from 1994
to 2002)
63
Mullins SEER- Non-Hispanic 80.6% 82.2% NR
2010 Medicare White 12.2% 10.7%
20163844 African American 7.2% 7.1%
Hispanic White (1998) (2002)
65
Cooperberg CaPSURE White – non 84.9% 86.8% NR
2002 Hispanic 11.1% 8.8%
12131295 Black/African 2.1% 1.6%
American 1.9% 2.9%
Hispanic (1989-97) (1997-
Other 2001)

C-57